Citation Impact
Citing Papers
OCEANS: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Chemotherapy With or Without Bevacizumab in Patients With Platinum-Sensitive Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
2012 Standout
Pegylated Liposomal Doxorubicin and Carboplatin Compared With Paclitaxel and Carboplatin for Patients With Platinum-Sensitive Ovarian Cancer in Late Relapse
2010
Randomized Phase II Placebo-Controlled Trial of Maintenance Therapy Using the Oral Triple Angiokinase Inhibitor BIBF 1120 After Chemotherapy for Relapsed Ovarian Cancer
2011
Species-Specific Recognition of Single-Stranded RNA via Toll-like Receptor 7 and 8
2004 StandoutScience
A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis
2021 StandoutScienceNobel
PARP inhibitors: Synthetic lethality in the clinic
2017 StandoutScience
T Cells Activated by Zwitterionic Molecules Prevent Abscesses Induced by Pathogenic Bacteria
2000
Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome
2004
EGFR Antagonists in Cancer Treatment
2008 Standout
Sepsis after major visceral surgery is associated with sustained and interferon-γ–resistant defects of monocyte cytokine production
2000
Antigen‐driven tissue‐specific suppression following oral tolerance: Orally administered myelin basic protein suppresses proteolipid protein‐induced experimental autoimmune encephalomyelitis in the SJL mouse
1994
Dendritic cells and epithelial cells: linking innate and adaptive immunity in asthma
2008
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor
1992
The Effect of Infections on Susceptibility to Autoimmune and Allergic Diseases
2002 Standout
Definitions for Response and Progression in Ovarian Cancer Clinical Trials Incorporating RECIST 1.1 and CA 125 Agreed by the Gynecological Cancer Intergroup (GCIG)
2011
Mechanisms linking obesity with cardiovascular disease
2006 StandoutNature
The antigenic identity of peptide-MHC complexes: A comparison of the conformations of five viral peptides presented by HLA-A2
1993
Ovarian cancer
2014 Standout
Pharmacological inhibitors of MAPK pathways
2002
Randomized phase II trial of carboplatin versus paclitaxel and carboplatin in platinum-sensitive recurrent advanced ovarian carcinoma: a GEICO (Grupo Español de Investigación en Cáncer de Ovario) study
2005
Optimal Chemotherapy Treatment for Women with Recurrent Ovarian Cancer
2007
Attachment of oligosaccharides to peptide antigen profoundly affects binding to major histocompatibility complex class II molecules and peptide immunogenicity
1994 StandoutNobel
Loss of Net as Repressor Leads to Constitutive Increased c-fos Transcription in Cervical Cancer Cells
2004 StandoutNobel
Glycosylation in Cellular Mechanisms of Health and Disease
2006 Standout
Regulatory T Cells and Immune Tolerance
2008 StandoutNobel
Selumetinib in women with recurrent low-grade serous carcinoma of the ovary or peritoneum: an open-label, single-arm, phase 2 study
2012
T cell responses to myelin basic protein in experimental autoimmune encephalomyelitis-resistant BALB/c mice
1993
Shared structural motifs in TCR of glycopeptide-recognizing T cell hybridomas
1999 StandoutNobel
Correlation between CA-125 serum level and response by RECIST in a phase III recurrent ovarian cancer study
2011
Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
2011 Standout
Cytokines in autoimmunity
1996
Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1
1993 StandoutNature
T cell recognition of Tn‐glycosylated peptide antigens
1996 StandoutNobel
PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
1998 StandoutNature
Combination cediranib and olaparib versus olaparib alone for women with recurrent platinum-sensitive ovarian cancer: a randomised phase 2 study
2014
An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis
1995
Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis
2000 Standout
The development of allergic inflammation
2008 StandoutNature
Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides
1994
Angiogenesis in life, disease and medicine
2005 StandoutNature
Revealing the human mucinome
2022 StandoutNobel
Antigen-specific therapeutic approaches for autoimmunity
2019
Recurrent low-grade serous ovarian carcinoma is relatively chemoresistant
2009
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
2020 Standout
Carbohydrates and antigen recognition by T cells
1997
Antisense sequences of antigenic peptides are found in MHC class II molecules
1991 StandoutNobel
Small cell lung cancer: the importance of the extracellular matrix
2004
Focal expression of interleukin-2 does not break unresponsiveness to "self" (viral) antigen expressed in beta cells but enhances development of autoimmune disease (diabetes) after initiation of an anti-self immune response.
1995 StandoutNobel
The Pathophysiology and Treatment of Sepsis
2003 Standout
Strategies for optimizing combinations of molecularly targeted anticancer agents
2006
Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease
2002 StandoutNature
T cell receptor antagonist peptides induce positive selection
1994 Standout
Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer
2012 Standout
Recent progress in the diagnosis and treatment of ovarian cancer
2011
Acute effects of cigarette smoke on inflammation and oxidative stress: a review
2004
Induction of virus‐specific cytotoxic T lymphocytes in vivo by liposome‐entrapped mRNA
1993
Lectin Domains of Polypeptide GalNAc Transferases Exhibit Glycopeptide Binding Specificity
2011 StandoutNobel
Management of Platinum-Sensitive Recurrent Ovarian Cancer
2006
Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 randomised trial
2013
HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release.
1995 StandoutNobel
Angiogenesis as a therapeutic target
2005 StandoutNature
An Immunomodulatory Molecule of Symbiotic Bacteria Directs Maturation of the Host Immune System
2005 Standout
Cyclophosphamide and Etoposide for Non-Small Cell and Small Cell Lung Cancer
1999
Cancer of the Ovary
2004 Standout
UDP-N-acetyl-α-D-galactosamine:polypeptide N-Acetylgalactosaminyltransferase
1995
Regulatory T Cell Clones Induced by Oral Tolerance: Suppression of Autoimmune Encephalomyelitis
1994 StandoutScience
Negative Selection during the Peripheral Immune Response to Antigen
2000
Proliferating dendritic cell progenitors in human blood.
1994 StandoutNobel
Virus and cytotoxic T lymphocytes: crucial role of viral peptide secondary structure in major histocompatibility complex class I interactions
1993
Identification and Characterization of Complex Glycosylated Peptides Presented by the MHC Class II Processing Pathway in Melanoma
2016
Structural characteristics of polysaccharides that induce protection against intra-abdominal abscess formation
1994
Sampling the Antibiotic Resistome
2006 StandoutScience
Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles.
1993
Cytotoxic T lymphocyte antigen-4 (CTLA-4) limits the expansion of encephalitogenic T cells in experimental autoimmune encephalomyelitis (EAE)-resistant BALB/c mice
2002 StandoutNobel
CD1d-Restricted and TCR-Mediated Activation of V α 14 NKT Cells by Glycosylceramides
1997 StandoutScience
Zwitterionic Polysaccharides Stimulate T Cells by MHC Class II-Dependent Interactions
2002
Avoiding horror autotoxicus: The importance of dendritic cells in peripheral T cell tolerance
2002 StandoutNobel
Targeted covalent inactivation of protein kinases by resorcylic acid lactone polyketides
2006
Mitogen-Activated Protein Kinase Pathways Mediated by ERK, JNK, and p38 Protein Kinases
2002 StandoutScience
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
2018 Standout
High Levels of a Major Histocompatibility Complex II–Self Peptide Complex on Dendritic Cells from the T Cell Areas of Lymph Nodes
1997 StandoutNobel
Combination of Antiangiogenic Therapy With Other Anticancer Therapies: Results, Challenges, and Open Questions
2005
Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer
2006 Standout
American Society of Clinical Oncology Clinical Practice Guideline Update on the Use of Chemotherapy Sensitivity and Resistance Assays
2011
CD1-Restricted T Cell Recognition of Microbial Lipoglycan Antigens
1995 Science
Cytotoxic T lymphocyte antigen-4 (CTLA-4) regulates the size, reactivity, and function of a primed pool of CD4+T cells
2000 StandoutNobel
Gemcitabine Plus Carboplatin Compared With Carboplatin in Patients With Platinum-Sensitive Recurrent Ovarian Cancer: An Intergroup Trial of the AGO-OVAR, the NCIC CTG, and the EORTC GCG
2006
CD4+CD25+regulatory T cells limit the risk of autoimmune disease arising from T cell receptor crossreactivity
2005
Tolerogenic Dendritic Cells
2003 StandoutNobel
Arylfluorosulfates Inactivate Intracellular Lipid Binding Protein(s) through Chemoselective SuFEx Reaction with a Binding Site Tyr Residue
2016 StandoutNobel
Peptides Presented to the Immune System by the Murine Class II Major Histocompatibility Complex Molecule I-A d
1992 Science
Induction of Antitumor Immunity by Vaccination of Dendritic Cells Transfected with MUC1 RNA
2000
Antigen acquisition by dendritic cells: intestinal dendritic cells acquire antigen administered orally and can prime naive T cells in vivo.
1993
Elicitation of structure-specific antibodies by epitope scaffolds
2010 StandoutNobel
Distinct influences of peptide-MHC quality and quantity on in vivo T-cell responses
2012 StandoutNobel
Works of Alan Lamont being referenced
IL-12: a key cytokine in immune regulation
1996
Five-Day Oral Etoposide2 Treatment for Advanced Small-Cell Lung Cancer: Randomized Comparison With Intravenous Chemotherapy
1997
Interaction of cigarette smoke and house dust mite allergens on inflammatory mediator release from primary cultures of human bronchial epithelial cells
2001
Biologic significance and therapeutic implications of antigen/MHC interactions
1989
A prospective randomized controlled trial of tumour chemosensitivity assay directed chemotherapy versus physician's choice in patients with recurrent platinum-resistant ovarian cancer
2007
High affinity for class II molecules as a necessary but not sufficient characteristic of encephalitogenic determinants
1992
Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial
2010
Fine Specificity of the Myelin-Reactive T Cell Repertoire: Implications for TCR Antagonism in Autoimmunity
1998
Priming of systemic and local delayed-type hypersensitivity responses by feeding low doses of ovalbumin to mice.
1989
The use of peptide analogs with improved stability and MHC binding capacity to inhibit antigen presentation in vitro and in vivo.
1990
A novel approach to the generation of high affinity class II-binding peptides.
1990
Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial
2003 Standout
Suppressor T cells, antigen-presenting cells and the role of I-J restriction in oral tolerance to ovalbumin.
1988
Effect of conformational propensity of peptide antigens in their interaction with MHC class II molecules. Failure to document the importance of regular secondary structures.
1989
Inhibition of experimental autoimmune encephalomyelitis induction in SJL/J mice by using a peptide with high affinity for IAs molecules.
1990
MHC interaction and T cell recognition of carbohydrates and glycopeptides
1992
Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of Marimastat After Response to First-Line Chemotherapy in Patients With Small-Cell Lung Cancer: A Trial of the National Cancer Institute of Canada-Clinical Trials Group and the European Organization for Research and Treatment of Cancer
2002
Ro 09-2210 Exhibits Potent Anti-proliferative Effects on Activated T Cells by Selectively Blocking MKK Activity
1998